Haleon (HLN) Change in Inventory (2022 - 2023)

Haleon (HLN) posted Change in Inventory of -$240.8 million for Q4 2023, down 34.17% on a QoQ basis from -$179.5 million in Q4 2022, and down 34.17% year-over-year from -$365.8 million in Q4 2022.

Haleon (HLN) Change in Inventory (2022 - 2023) Analysis & Trends

Haleon's Change in Inventory history runs 2 years deep, the most recent figure standing at -$240.8 million for Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -93.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 114.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 119.24 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 40.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 123.00 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -4.30 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 2.20 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 -240.78 Mn
Dec 31, 2023 -240.78 Mn
Dec 31, 2022 -179.46 Mn
Dec 31, 2022 -179.46 Mn